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Membrane repairMechanically damaged plasma membrane undergoes rapid calcium-dependent resealing that appears to
depend, at least in part, on calpain-mediated cortical cytoskeletal remodeling. Cells null for Capns1, the non-
catalytic small subunit present in both m- and μ-calpains, do not undergo calcium-mediated resealing.
However, it is not known which of these calpains is needed for repair, or whether other major cytosolic
proteinases may participate. Utilizing isozyme-selective siRNAs to decrease expression of Capn1 or Capn2,
catalytic subunits of μ- and m-calpains, respectively, in a mouse embryonic ﬁbroblast cell line, we now show
that substantial loss of both activities is required to compromise calcium-mediated survival after cell scrape-
damage. Using skeletal myotubes derived from Capn3-null mice, we were unable to demonstrate loss of
sarcolemma resealing after needle scratch or laser damage. Isolated muscle ﬁbers from Capn3 knockout mice
also efﬁciently repaired laser damage. Employing either a cell line expressing a temperature sensitive E1
ubiquitin ligase, or lactacystin, a speciﬁc proteasome inhibitor, it was not possible to demonstrate an effect of
the proteasome on calcium-mediated survival after injury. Moreover, several cell-permeant caspase
inhibitors were incapable of signiﬁcantly decreasing survival or inhibiting membrane repair. Taken together
with previous studies, the results show that m- or μ-calpain can facilitate repair of damaged plasma
membrane. While there was no evidence for the involvement of calpain-3, the proteasome or caspases in
early events of plasma membrane repair, our studies do not rule out their participation in downstream
events that may link plasma membrane repair to adaptive remodeling after injury.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Cells are constantly exposed to mechanical stresses that produce
breaks in their plasma membranes [1–3]. This is readily observed in
tissues predicted to be at greatest risk for membrane damage. For
example, skeletal muscle myocytes [4] and cardiomyocytes [5], which
must routinely contract against mechanical or pressure loads, were
shown to allow entry of serum albumin or cell impermeant dyes in
their cytosolic compartments, consistent with ongoing contraction-
dependent sarcolemmal injury. Recent studies from several laborato-
ries indicate that a discrete mechanism has evolved to repair injured
plasma membrane. It is thought that calcium-dependent fusion of
intracellular vesicles underlying the ruptured plasma membrane+1 419 383 2871.
ellgren).
niversity, Takamatsu, Kagawa,
ll rights reserved.creates a large vesicle patch, which rapidly translocates to the site of
damage. There it fuses with the ruptured plasmamembrane to quickly
restore the permeability barrier that all living cells require.
While the molecular events underlying membrane repair are as
yet poorly deﬁned, several candidate repair proteins have been
identiﬁed; including vSNARE and tSNARE components that regulate
vesicle fusion with plasma membrane in exocytosis [6]; the multiple
C2 domain protein dysferlin, that appears to be required for efﬁcient
repair of damaged skeletal [7] and cardiac [8] muscle sarcolemma;
and annexin-A1, a calcium and phospholipid binding protein [9].
Recently, the intracellular calcium-dependent proteinases, calpains,
have been shown to be required for calcium-mediated repair of
damaged plasma membrane in cultured ﬁbroblasts and some other
cell types [10]. It is thought that they clear cortical cytoskeletal
remnants at the injury site, facilitating vesicle patch fusion with the
torn plasma membrane [3,11]. Initial studies strongly argued that a
ubiquitous heterodimeric calpain, m- or μ-calpain, was required for
repair. However, it is still not known if both isozymes have this
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proteinases could also be indispensable for rapid, complete removal of
damaged cortical cytoskeleton, or to catalyze other events required
for prompt wound resealing. Inactivating mutations of the CAPN3
gene, encoding the muscle-speciﬁc calpain-3, result in a limb-girdle
muscular dystrophy: LGMD-2A [12]. Moreover, calpain-3 associates
with putative membrane repair proteins at the plasma membrane,
including dysferlin [13]. Thus, it would be interesting to know if
calpain-3 is also required for repair of wounded skeletal muscle
sarcolemma. In addition, other major intracellular proteinases, the
proteasome and caspases, participate in a number of physiologic and
pathophysiologic processes, and might also contribute to plasma
membrane repair. We now provide evidence that m- or μ-calpain can
affect repair. However, calpain-3, the proteasome and caspases do not
appear to be required.
2. Materials and methods
2.1. Materials
The following siRNA constructs were obtained from Qiagen;
Capn1: AA-UAUCCCUCUGCAAACCAAA-dTdT. Capn2: AA-GGUCAGAG-
GAAGCGUUACA-dTdT.
Control siRNA: AA-UUCUCCGAACGUGUCACGU-dTdT. FM1-43 and
its paraformaldehyde ﬁxable analog, FM1-43FX, were purchased from
Molecular Probes. Calpeptin, lactacystin, kFGF-DEVD aldehyde kFGF-
YVAD aldehyde, ZVAD-CH2F, and N-acetyl-YVAD aldehyde were
obtained from Calbiochem. ECL extracellular matrix preparation,
and 100× insulin-transferrin-selenium stock solution (Gibco product
number 51500-056) were purchased from Invitrogen.
2.2. Cell culture
Capns1−/−, Capns1+/+, Capns1−/−R, ts20B, and H38-5 mouse
ﬁbroblast cell lines were routinely cultured in humidiﬁed 5% CO2, in
DMEM medium supplemented with 10% FBS. The Capns1 cell lines
were cultured at 37 °C. The ts20B and H38-5 cell lines were routinely
cultured at 33 °C (permissive temperature for the ts20B cells). To
inactivate themutated E1 ubiquitin ligase in the ts20B cells, theywere
shifted to 39 °C 16 h before being scrape-damaged. The H38-5 control
cells were heat-treated under identical conditions. The C2C12 mouse
myoblast cell line, Capn3−/− myoblasts, and Capn3+/+ myoblasts
derived fromwild type littermates, were cultured in 37 °C, humidiﬁed
5% CO2 in Hams F10 medium containing 20% FBS and 5 ng/ml bFGF.
Myotubes were prepared by allowing myoblasts to grow to
conﬂuence on culture dishes coated with ECL. Medium was then
changed to DMEM supplemented with insulin, transferrin and
selenium, and was exchanged for fresh medium every day thereafter.
After 4 days, the differentiated myotubes were subjected to needle-
scratch injury.
2.3. Animals
All procedures on animals were performed according to the
European guidelines for the humane care and use of experimental
animals. The experiments were approved by the French Ministry of
Research and Education (Agreement decision B91 228-101). C57BL/6
mice were purchased from Charles River Laboratories (Les Oncins,
France). The Capn3-null mice used in these studies were described in
Ref. [14].
2.4. Calpain expression knockdown studies
The catalytic subunits of m-calpain and μ-calpain in Capns1+/+
SV40-Large T-antigen transformed ﬁbroblasts were downregulated by
transfecting with siRNA constructs, employing a standard protocol.Cells were transfected with a Lipofectamine 2000:siRNA complex
when approximately 30% conﬂuent in 6-well plates. The conditions
recommended by the Lipofectamine 2000 manufacturer (Invitrogen)
were followed. The ﬁnal transfection medium was 0.5 ml Optimem®
medium containing 100 nMol of total siRNA complexed with 10 μl of
Lipofectamine 2000. Four different conditions were employed: (1)
control, 100 nMol of control siRNA; (2) μ-calpain knockdown, 50 nMol
of control siRNA plus 50 nMol Capn1 siRNA; (3) m-calpain
knockdown, 50 nMol control siRNA plus 50 nMol Capn2 siRNA; 4)
double knockdown, 50 nMol each of Capn1 and Capn2 siRNAs. This
protocol ensured that the total concentration of siRNA and ratio of
siRNA to Lipofectamine was the same in all experimental conditions.
Cells were allowed to recover for 48 h, and then trypsinized and
transferred to 12-well plates. The next day, 72 h after siRNA
treatment, the cells were scrape-damaged and analyzed for survival,
as described below.
Other samples of siRNA-treated cells were lysed in 25 mM MOPS
buffer, pH 7.2, containing 0.5 mM EGTA, 0.5 mM dithiothreitol,
150 mM NaCl, 0.2% Triton X-100, and analyzed for μ- and m-calpain
content by casein zymography, as previously described [15]. Brieﬂy,
protein in cell lysates was determined by the BCA method [16], and
15 μg of each sample was applied to a 12% non-denaturing
polyacrylamide gel co-polymerized with 2 mg casein/ml. After
electrophoresis, the gel was incubated in 50 mM Tris–HCl, 5 mM
CaCl2 , 5 mM dithiothreitol, pH 7.3. Sixteen hours later, the gel was
stained with Coomassie blue dye. Calpains were detected by lack of
Coomassie staining (absence of casein) at their positions in the gel.
Bovine m-calpain and human μ-calpain, puriﬁed as previously
described [17], were applied to the same gel to mark the location of
the endogenous calpains. RGB tif images of scanned gels were
analyzed for band brightness using the NIH ImageJ program and the
default RGB brightness conversion factor. Regions of the zymograms
without sample loads provided background brightness levels. Because
of low levels of calpain activity in the calpain siRNA-treated samples,
no attempt wasmade to quantitate calpain in the zymograms, and the
results should be interpreted as a qualitative assessment of calpain
downregulation.
2.5. Cell survival assay
Cells were cultured in 12-well plates until 30–50% conﬂuent. They
were then scraped with a small plastic cell scraper (Corning product
number 3010) in PBS containing 1.5 mM CaCl2 or 2 mM EGTA as
previously described [10]. The injured cells were allowed to recover,
and assayed for mitochondrial MTT reductase activity [18]. It was
previously shown that this assay is consistent with other measures of
cell survival, including direct cell counting and clonal survival assays
[10]. In some experiments, recovery of plasma membrane integrity
1min after scrapingwas assessed by trypan blue uptake, as previously
described [10]. To investigate the effect of protease inhibitors on
survival, cells were cultured with the inhibitors for 2 h prior to
scraping. They were then scraped in buffer containing inhibitor, at the
same concentration.
2.6. Cell damage protocols
Cells were subjected to needle-scratch damage [10], or laser injury
[19] as previously described. Needle-scratch injury was carried out in
the presence of 5 μMFM1-43FX in PBS containing 1.5mMCaCl2, 2 mM
EGTA, or 1.5 mM CaCl2 and 20 μM calpeptin. Myotubes derived from
Capn3-null mouse myoblasts [20] were used in these experiments.
Myotubes scratched in the presence of calpeptin were ﬁrst pre-
incubated for 2 h in culture medium containing 20 μM calpeptin. One
minute after scratching, the myotubes were ﬁxed on ice for 10 min
with 4% paraformaldehyde in PBS. The myotubes were washed 4
times with PBS, and subjected to epiﬂuorescence microscopy using a
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adjacent to the scratch zone were subjected to image analysis using
the NIH ImageJ program. Fluorescence intensity normalized for cell
area was compared for myotubes scratched in the presence of
calcium, EGTA, or calcium plus calpeptin.
Skeletal muscle myoblasts or derived myotubes from Capn3-null
mice [14] were wounded in the presence or absence of 1 mM calcium,
using the 820 nm infrared laser of a two photon microscope (LSM
510META, Zeiss and MIRA 900 System, Coherent). Resealing analysis
wasbased on thekinetics andextent of FM1-43dyeentry throughopen
disruptions [19]. The cells were maintained at 37 °C during imaging.
For laser injury of isolated muscle ﬁbers, the following procedure
was used. Isolated Flexor Digitorum Brevis (FDB) muscles of 7- to
8-week-old Capn3-null [14] or C57BL/6 mice were digested in DMEM
containing 1% collagenase A under slow rotation at 37 °C for 2–3 h.
The digest was washed 4 to 5 times with PBS without calcium or
magnesium ion, and resuspended to a ﬁnal volume of 2ml in the same
buffer. Approximately one half of the ﬁbers isolated from both Capn3-
null and control cells were damaged during the preparation of muscle
ﬁbers, as observed by hypercontraction and spontaneous FM1-43 dye
uptake. Only undamaged ﬁbers were assessed for repair of laser
injury. Before performing the membrane repair assay, the preparation
was adjusted to 100 μM calcium and 4 μM FM1-43. To induce damage,
an area of the sarcolemma on the membrane of the muscle ﬁber was
irradiated at full power for 1 secondwith a two-photon confocal laser-
scanning microscope. The Multi-Photon Microscope consisted of a
Radiance 2100 MP scan head (Bio-Rad) equipped with a mode-locked
Titanium-Sapphire laser system (Coherent Verdi-Mira) pumped atFig. 1. The Capns1−/−R rescued ﬁbroblast cell line expresses limited calpain activity,
but shows partial recovery of calcium-mediated cell survival after scraping. (A) Casein
zymogram of Capns1 cell lines. Cell lysates were subjected to zymography as described
in Materials and methods. The μ- and m-calpain bands are shown, as assessed by the
migration of puriﬁed human μ- and bovine m-calpains, respectively. Lanes are from the
same zymogram, but were separated to prevent sample “bleedover.” (B) Relative
intensity of m-calpain bands from three independent zymography experiments, using
the NIH imageJ software program to estimate brightness of the cleared casein zones.
(C) Capns1−/−R cells were scraped with the indicated additions, as described in
Materials and methods, and allowed to recover for 12 h before assessing cell survival.
CP=20 μM calpeptin. Asterisk: P=0.002 vs. EGTA sample (N=6). (D) Capns1−/−,
Capns1−/−R, and Capns1+/+ ﬁbroblasts were cultured to 30–50% conﬂuence, and
scraped in the presence of calcium. Asterisk: Pb0.001 vs. Capns1−/−. Double asterisk:
Pb0.001 vs. Capns1−/−R.10W and tuned to 800 nm excitation with 100 fs pulses at 76 MHz.
The microscope was an inverted Nikon TE300 (Nikon Instech Co.)
with Nikon objectives (dry CFI Plan APO, 20× NA0.75). Images were
captured for 3 min after the irradiation at 7-s intervals. Images were
represented in an inverted 16-color look up table of ImageJ. For every
image taken, the ﬂuorescence intensity at the site of the damage was
measured by ImageJ on an area of about 0.01 mm2. The rate of
ﬂuorescence inﬂux for all ﬁbers in the same group was plotted on a
histogram.
2.7. Statistical analysis
Except where otherwise indicated, results are presented as experi-
mental mean plus or minus standard deviation. Statistical signiﬁcance
was assessed using Student's t-test, and Pb0.05 was considered
signiﬁcant.
3. Results
Previous studies demonstrated that SV-40 large T-antigen trans-
formed ﬁbroblasts derived from Capns1-null embryos failed to reseal
upon laser injury in the presence of millimolar Ca2+. Moreover, their
percent survival after scrape-damage was not increased by Ca2+ [10].
To be certain that loss of the calpain small subunit, encoded by Capns1
was responsible for this loss of calcium-dependent membrane repair,
itwas essential to showgain of function byCapns1 re-expression in the
knockout background. Capns1−/−R, a rescued strain that expresses aFig. 2. Calcium-dependent survival after scraping requires the typical, ubiquitous
calpains. (A) Capns1+/+ ﬁbroblasts were transfected with the indicated siRNAs. After
72 h, the cells were lysed and subjected to casein zymography to assess loss of μ- and
m-calpain activity. The inset shows results of one experiment. The graph presents data
from three experiments. Asterisks: Pb0.02 vs. corresponding control siRNA. (B) Other
samples were scraped and viability was determined 16 h later. Details are provided in
Materials and methods. Asterisk: P=0.005 vs. no siRNA addition (N=4).
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calpain activity, assessed by casein zymography, as well as recapitu-
lation of the wild-type cell motility phenotype [21]. We conﬁrmed by
casein zymography that m-calpain activity was detectable in the
Capns1−/−R cells employed in our studies (Fig. 1A). No μ-calpain
activity was detected in the Capns1−/−R cells, and, as expected, the
Capns1−/− cells displayed neitherm-calpain nor μ-calpain activities in
the zymogram (Fig. 1A). Qualitative assessment of band brightness in
the zymograms suggested that the Capns1−/−R cells displayedmodest
m-calpain activity compared with wild-type (Fig. 1B). Several
experiments with Capns1−/−R showed that calcium-dependent
percent survival after scrape damage was restored (Fig. 1C), albeit to
a lower extent than observed in wild-typemouse ﬁbroblasts (Fig. 1D).
This is consistent with the requirement of calpain small subunit for
survival. However, because Capns1 encodes the small subunit present
in both m- and μ-calpains, these studies could not show which of the
ubiquitous, typical calpains was required for cell survival.
Differential depletion of m- and μ-calpain large subunits has been
achieved by siRNA-mediated knockdown [22]. Importantly, depletionFig. 3. Calcium-dependent repair of damaged sarcolemma is not compromised in
myotubes derived from Capn3-null mice. (A) Myotubes prepared from Capn3−/−
myoblasts were subjected to needle scratch damage in the presence of FM1-43FX dye.
The dotted white lines indicate the sites of scratch injury. Dye uptake for the ﬁrst
minute after damage was semi-quantitatively assessed as described in Materials and
methods (asterisk: P=0.014 vs. EGTA samples). Numbers in parentheses refer to the
total number of scratch sites analyzed in two different culture dish wells. Upper panel
depicts typical results for each injury condition. (B) Laser injury of Capn3−/− and
Capn3+/+ myotubes, as described in Materials and methods. Except where noted, cells
were injured in the presence of 1 mM CaCl2. As noted in many previous studies,
calcium-mediated resealing of wounded membrane rapidly prevents accumulation of
dye, as shown by injury of C2C12 myotubes in the presence of calcium compared with
EGTA. Note that both Capn3−/− and Capn3+/+ myotubes (red and green triangles,
respectively) resealed efﬁciently.of one subunit did not appear to noticeably affect expression of the
other. We therefore employed the well-characterized siRNA
sequences to deplete expression of m-calpain, μ-calpain, or both
large subunits, and assessed the impact on calcium-mediated survival
after scrape damage. In three independent experiments, we noted
substantial depletion of either m- or μ-calpain activity, as indicated by
decreased relative band brightness on casein zymograms, using the
protocol described in Materials and methods (Fig. 2A). The control
siRNA had no apparent inﬂuence on expression of either calpain, as
assessed by casein zymography, and exposure of cells to both calpain
siRNAs together appeared to produce the same effect on their cognate
targets as when they were applied separately (Fig. 2A). Depletion of
either calpain alone had at best a modest effect on survival after
scrape damage. However, in three independent studies, this reduction
in survival was not statistically signiﬁcant. In contrast, combining the
two siRNAs resulted in a reproducible, but incomplete, inhibition of
calcium-mediated survival (Fig. 2B). Importantly, there was no
signiﬁcant effect on survival after scraping in the presence of EGTA
in this experiment, or in either of the other replicate experiments,
arguing against a simple increase in cell toxicity by combining the
siRNAs. Taken together with the results presented in Fig. 1, and with
our previous studies that strongly implicated calpains in plasma
membrane repair [10,11], these experiments indicate that either m-
or μ-calpain can bring about repair, and that even modest calpain
levels are sufﬁcient for at least partial protection.
Calpain-3 is localized at the skeletal muscle M-line, Z-band, and
the N2A region of the large myoﬁbrillar protein, titin (also called
connectin) [23,24]. While it has been speculated that calpain-3 may
participate in sarcolemma repair [25], there is no direct evidence to
support this function. In fact, recent studies indicate that nearly all
calpain-3 in mature rat muscle ﬁbers is associated with the contractileFig. 4. Membrane repair and calcium-dependent cell survival are not signiﬁcantly
compromised in injured Capn3−/−myoblasts. Myoblasts were subjected to laser injury
(A) or scrape injury (B) using the standard protocols for each (see Materials and
methods). Symbols are the same as in Fig. 3. Asterisks: Pb0.005 vs. EGTA samples.
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of calpain-3 is released from contractile ﬁlament binding sites
following injury, and participates in membrane repair. In keeping
with this possibility, calpain-3 appears to be capable of cleaving
several sarcolemma-associated proteins, including talin, α-actinin,
vinexin, ezrin [27], γ-ﬁlamin [28], and β-catenin [29]. To investigate
the possible function of calpain-3 in sarcolemma repair, myotubes
derived from two calpain-3 knockout mouse strains [14,20] were
subjected to membrane damage protocols. FM1-43FX uptake through
needle-scratch damage, as described in Materials and methods, was
signiﬁcantly less when calciumwas present in the medium (P=0.014
vs. EGTA sample, Fig. 3A), an indication that Capn3-null myotubes still
have the ability to undergo calcium-dependent resealing. Calpeptin
prevented the effect of calcium addition, suggesting that μ- and
m-calpain-mediated repair is normal in these cells. Capn3-null
myotubes recovered from laser injury at least as well as wild type
(Fig. 3B). Although the Capn3-null myotubes appeared to resealFig. 5. Comparison of membrane repair capacity between Capn3-null and C57BL/6 mice (A
Capn3-null mice. Images are represented in a “16 colors inverted” look up table (table dep
injury. The time at which each picture was taken is also indicated. The two left panels show
The right panel shows a representative repair assay performed on Capn3-null ﬁbers.
(Δ[ﬂuorescence]/Δt) in ﬁbers of C57BL/6 w/o Ca2+, w/ Ca2+ and Capn3-null w/ Ca2+. The
Statistical analysis was performed with Student's t-test.somewhat better than wild-type in this experiment, this degree of
variability is not uncommon within the experimental system
employed. Importantly, neither cell type displayed the dramatic,
continuous uptake of dye observed when membrane repair is blocked
by elimination of calcium (compare C2C12 myotubes±calcium, Fig.
3B), dysferlin deﬁciency [7], or calpain small subunit ablation [10].
Capn3-null myoblasts also resealed quickly after laser injury (Fig. 4A).
The cell scraping protocol routinely employed to assess ﬁbroblast
survival is not applicable to myotubes, which survive mechanical
removal from their growth substrate poorly, if at all. However, it was
possible to subject myoblasts to scrape damage. The latter did not
appear to bind as avidly to plastic cultureware; thus, they were not
injured as much as the ﬁbroblasts we routinely employ, as shown by
their increased percent survival under all conditions (Fig. 4B).
However, it was apparent that loss of calpain-3 did not alter their
calcium-dependent survival. As with other cell types, calpeptin
completely prevented calcium-dependent survival of the Capn3−/−) A membrane repair assay was performed on single muscle ﬁbers from C57BL/6 and
icted at the bottom of the left panel) from ImageJ software. Arrows indicate the site of
a representative assay performed on C57BL/6 ﬁbers without (w/o) or with (w/) Ca2+.
Scale bar=100 μm. (B) Histogram representing the rates of ﬂuorescence inﬂux
ﬁbers were sampled from 3 different mice for each condition. Data are means±s.e.m.
Fig. 7. Proteasome and caspases do not appear to contribute to survival after scrape
damage, or to acute repair of damaged plasma membrane. (A) Capns1+/+ cells were
preincubated with protease inhibitors as described in Materials and methods, and then
subjected to scrape damage in the presence of calcium and inhibitors. Concentrations of
inhibitor used were: calpeptin (CP), 20 μM; lactacystin (lacta), 5 μM; DEVD, 2 μM;
YVAD, 2 μM; ZVAD, 10 μM. Asterisks: Pb0.01 vs. paired EGTA samples (N=4). (B)
Capns1+/+ cells were treated with inhibitors, scraped in the presence of calcium, and
analyzed for trypan blue (TPB) uptake 1 min after scraping.
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μ-calpain, in calcium-dependent repair. As a ﬁnal test of calpain-3
function in repair of intact native muscle ﬁbers, isolated muscle ﬁbers
from Capn3−/−mice were subjected to laser injury in the presence of
FM 1-43 dye as described in Materials and methods. Consistent with
our other studies, the Capn3−/− muscle ﬁbers recovered as well as
muscle ﬁbers derived fromwild-type mice (Fig. 5). Overall, the results
of our studies suggest that calpain-3 does not participate signiﬁcantly
in rapid sarcolemma repair after various types of mechanical injury.
Other major cytosolic proteolytic activities include the ubiquitin-
proteasome system, and the caspases. Ubiquitin-signaled proteasomal
proteolysis of regulatory proteins mediates many intracellular path-
ways, including those involved in cell survival [30–32], a function that
would logicallyﬁtwith their possible effect onplasmamembrane repair.
Caspases are predominantly associated with regulated cell death.
However, they appear to have a more diverse role in cell physiology
than previously recognized, including the potential of caspase-1 to
promote cell survival [33,34]. We therefore determined whether the
proteasomeor caspasesmight be required for plasmamembrane repair.
We utilized the ts20b E1-ubiquitin ligase temperature sensitive
mutant cell line [35] to investigate the role of the ubiquitin-
proteasome system in survival after plasma membrane damage.
These cells can produce polyubiquitinated proteasome substrates at
33 °C, but not at 39 °C, thus limiting proteasomal degradation at the
higher temperature. The ts20b and the control H38-5 cell lines both
displayed calcium-dependent increase in survival after scrape
damage, irrespective of their growth at 33 °C or 39 °C, the permissive
and restrictive temperatures for ts20b E1-ligase, respectively (Fig. 6).
Some proteins do not require ubiquitination prior to processing by the
proteasome. Therefore, to directly assess its involvement in recovery
from plasma membrane damage, proteasome activity in mouse
ﬁbroblasts was inhibited by preincubation with the proteasome-
speciﬁc active site alkylating agent, lactacystin. In the same experi-
ment, other cells were pre-incubated with acetyl-YVAD-CHO or kFGF-
DEVD-CHO, cell permeant inhibitors of caspase-1 and caspase-3,
respectively. ZVAD-CH2F, a cell permeant pan-caspase inhibitor, was
also included in these studies. The concentrations of kFGF-DEVD-CHO
and ZVAD-CH2F employedwere near themaximumeffective doses for
inhibition of Capns1+/+ apoptotic cell death induced by exposure to
hydroxyurea (data not shown). Survival of scrape-damaged cells was
increased by calcium, independent of proteasome or caspase
inhibition (Fig. 7A). In a separate experiment another caspase-1
inhibitor, kFGF-YVAD-CHO, also had no apparent inﬂuence on
calcium-mediated survival (data not shown).
The protease inhibitors, especially the caspase inhibitors, could
produce opposing effects on cell survival after membrane damage.
They might inhibit membrane resealing, thus promoting cell death,Fig. 6. Recovery after scrape-damage is not compromised in a ubiquitin ligase mutant
cell line. A ubiquitin E1 ligase temperature sensitive mutant ﬁbroblast cell line (ts20B)
and H38-5 control cell line were cultured at permissive (33 °C) or restrictive (39 °C)
temperatures prior to scrape-damage and survival analysis as described in Materials
and methods. Asterisks: P≤0.02 vs. paired EGTA samples (N=4).but counteract caspase-dependent apoptosis occurring after mem-
brane damage, thereby promoting survival. To directly assess the
inﬂuence of the inhibitors on membrane resealing after scrape
damage, we employed the trypan blue uptake assay previously
utilized to show rapid resealing of Capns1+/+ but not Capns1−/− cells
[10]. Consistent with the survival studies, the inhibitors did not
signiﬁcantly delay membrane resealing (Fig. 7B). Thus, the cell
survival observed upon treatment with these inhibitors appears to
be the result of normal plasma membrane repair.
4. Discussion
Previous studies have highlighted a role for the ubiquitous, typical
calpains in plasma membrane repair [10]. However, these studies
employed Capns1-null cells or treatment with inhibitors that cannot
sufﬁciently discriminate between the ubiquitous, typical calpains. It
was therefore not possible to determine whether endogenously
expressed μ- or m-calpain was needed for repair. Capn2-ablated
mouse embryos die very early in development, before embryonic
ﬁbroblasts can be obtained [36]; therefore, it has not been possible to
use this knockout model to differentiate roles of m-calpain and μ-
calpain in plasma membrane repair. Our gene knockdown studies
(Fig. 2) provide the ﬁrst molecular genetic evidence that either m- or
μ-calpain can support calcium-dependent plasma membrane repair.
The results are consistent with previous studies showing that pre-
loading Capns1-null ﬁbroblasts with either puriﬁed m- or μ-calpain
restored calcium-mediated recovery following scrape-damage [10].
This broadens the potential scope of calpain-mediated repair, because
while many mammalian cells express both m- and μ-calpain, some
cells express predominantly one of these two isozymes [37]. Because
μ-calpain requires less calcium for activity than m-calpain, it is
possible that cells expressing predominantly the former isozyme may
have enhanced ability to repair membrane breaks in the presence of
1892 R.L. Mellgren et al. / Biochimica et Biophysica Acta 1793 (2009) 1886–1893less damage, and hence lower localized calcium concentrations. On
the other hand, there may be cell or tissue-speciﬁc requirements for
one or the other ubiquitous calpain. It is worth noting that m-calpain
was selectively upregulated in mechanically loaded rat skeletal
muscle, while μ-calpain expression was unchanged [38]. Therefore,
there appears to be a redundant role for the ubiquitous calpains in
membrane repair, and probably other calpain functions as well.
However, a degree of selectivity may occur at the tissue level due to
upregulation of one isoform over the other.
We were very interested in the possibility that calpain-3 was
involved in sarcolemma repair. The dysferlinopathies, LGMD-2B and
Miyoshi myopathy, are associated with compromised skeletal muscle
sarcolemma repair, owing to mutation of the dysferlin gene.
Interestingly, dysferlinopathy is sometimes associatedwith decreased
calpain-3 expression [39], and there is evidence that calpain-3
associates with dysferlin in muscle [13]. While myoblasts do not
express the calpain-3 splice variants observed in mature muscle, they
do express an alternative splice variant which could potentially
participate inmembrane repair [40]. Calpain-3 did not appear to affect
membrane repair in the myoblast, myotube, and muscle ﬁber model
systemswe have employed (Figs. 3–5). Nevertheless, it is an attractive
candidate for initiating remodeling of the sarcomere secondary to
membrane damage, and it becomes activated in human skeletal
muscle in the ﬁrst 24 h after eccentric exercise [41]. Calpain-3 is
capable of processing several proteins that are required for normal
sarcomere structure, or sarcomere-membrane association [27,28],
and might be involved in reorganization of this structure in the ﬁrst
24 h after sarcolemma damage. This hypothesis predicts that calpain-
3 substrate processing will occur after rapid membrane repair, an idea
that can be readily tested in model systems deﬁned in the present
work and in previous studies. Recent evidence suggests that AHNAK, a
dysferlin- and actin-binding protein, is a substrate for calpain-3 [42],
lending further support for its involvement in post-injury sarcolem-
mal and cortical cytoskeletal remodeling. Assessment of the role of
calpain-3 in recovery after membrane repair will require the use of
mouse models in long-term studies.
Neither the ubiquitin-proteasome system nor caspases appeared
to be required for calcium-mediated membrane repair or survival.
However, long-term remodeling of cell or tissue structure after
membrane damage may rely on proteasome or caspases. Past studies
of human skeletal muscle recovery after moderately damaging
eccentric exercise [43] are consistent with this notion. It was found
that m-calpain expression was rapidly increased in the ﬁrst day after
exercise. The present study suggests that this may be in response to
the initial damage, and in preparation for continued sarcolemma
repair in case of immediate further damage. The proteasome system,
and lysosomal cathepsins B and L were not upregulated until 1 to
2 weeks after damage [43], at a time when they might be involved in
long-term muscle remodeling.
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